216 related articles for article (PubMed ID: 9070210)
1. Mechanism involved in the antiplatelet activity of naloxone in human platelets.
Sheu JR; Hung WC; Lee LW; Chang PT; Kan YC; Yen MH
Biochem Biophys Res Commun; 1997 Feb; 231(1):12-6. PubMed ID: 9070210
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets.
Sheu JR; Hsiao G; Chou PH; Shen MY; Chou DS
J Agric Food Chem; 2004 Jul; 52(14):4414-8. PubMed ID: 15237945
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory mechanisms of naloxone on human platelets.
Sheu JR; Lee YM; Lee LW; Luk HN; Yen MH
Clin Exp Pharmacol Physiol; 1998; 25(7-8):585-91. PubMed ID: 9673433
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavoviridis snake venom.
Huang TF; Sheu JR; Teng CM
Thromb Haemost; 1991 Oct; 66(4):489-93. PubMed ID: 1665595
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets.
Sheu JR; Kan YC; Hung WC; Ko WC; Yen MH
Thromb Res; 1997 Nov; 88(3):259-70. PubMed ID: 9526946
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation.
Lee YM; Lee JJ; Shen MY; Hsiao G; Sheu JR
Eur J Pharmacol; 2006 May; 537(1-3):52-8. PubMed ID: 16624282
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
[TBL] [Abstract][Full Text] [Related]
9. Morphine-potentiated agonist-induced platelet aggregation through alpha2-adrenoceptors in human platelets.
Sheu JR; Yeh GC; Fang CL; Lin CH; Hsiao G
J Cardiovasc Pharmacol; 2002 Nov; 40(5):743-50. PubMed ID: 12409983
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.
Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH
Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms involved in the antiplatelet activity of magnesium in human platelets.
Sheu JR; Hsiao G; Shen MY; Fong TH; Chen YW; Lin CH; Chou DS
Br J Haematol; 2002 Dec; 119(4):1033-41. PubMed ID: 12472585
[TBL] [Abstract][Full Text] [Related]
12. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction.
Liu CZ; Huang TF
Arch Biochem Biophys; 1997 Jan; 337(2):291-9. PubMed ID: 9016825
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets.
Sheu JR; Lee CR; Lin CH; Hsiao G; Ko WC; Chen YC; Yen MH
Thromb Haemost; 2000 May; 83(5):777-84. PubMed ID: 10823277
[TBL] [Abstract][Full Text] [Related]
14. The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C.
Sheu JR; Kan YC; Hung WC; Su CH; Lin CH; Lee YM; Yen MH
Thromb Res; 1998 Oct; 92(2):53-64. PubMed ID: 9792112
[TBL] [Abstract][Full Text] [Related]
15. C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis.
Hsiao G; Chou PH; Shen MY; Chou DS; Lin CH; Sheu JR
J Agric Food Chem; 2005 Oct; 53(20):7734-40. PubMed ID: 16190625
[TBL] [Abstract][Full Text] [Related]
16. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
[TBL] [Abstract][Full Text] [Related]
17. The antiplatelet activity of Geiji-Bokryung-Hwan, Korean traditional formulation, is mediated through inhibition of phospholipase C and inhibition of TxB(2) synthetase activity.
Park WH; Kim KS; Kim KH; Kim DS; Kim CH
Int Immunopharmacol; 2003 Jul; 3(7):971-8. PubMed ID: 12810354
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of antiplatelet and antithrombotic activity of midazolam in in vitro and in vivo studies.
Hsiao G; Shen MY; Chou DS; Chang Y; Lee LW; Lin CH; Sheu JR
Eur J Pharmacol; 2004 Mar; 487(1-3):159-66. PubMed ID: 15033388
[TBL] [Abstract][Full Text] [Related]
19. Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets.
Wang W; Wang YP; Sun WK; Xu YM; Xuan LJ
Acta Pharmacol Sin; 2000 Sep; 21(9):859-63. PubMed ID: 11501172
[TBL] [Abstract][Full Text] [Related]
20. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity.
Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK
Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
